Sagent Pharmaceuticals has announced the temporary importation of 8.4% Sodium Bicarbonate Injection, USP into the US market from Australia-based Phebra. The temporary arrangement is to address the present critical shortage of non-FDA ...
Tags: Sagent, Sodium Bicarbonate Injection, drug, drug shortage